Quantum-Si incorporated (NASDAQ:QSI) Stock Position Trimmed by GSA Capital Partners LLP

GSA Capital Partners LLP decreased its position in Quantum-Si incorporated (NASDAQ:QSI) by 38.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 112,317 shares of the company’s stock after selling 69,960 shares during the period. GSA Capital Partners LLP owned approximately 0.08% of Quantum-Si worth $99,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. XTX Topco Ltd acquired a new position in Quantum-Si during the 2nd quarter valued at about $25,000. Public Employees Retirement System of Ohio purchased a new position in shares of Quantum-Si in the first quarter worth approximately $27,000. SG Americas Securities LLC purchased a new position in Quantum-Si during the 3rd quarter worth approximately $53,000. Virtu Financial LLC acquired a new position in Quantum-Si during the first quarter valued at $98,000. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of Quantum-Si by 11.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 59,727 shares of the company’s stock worth $118,000 after purchasing an additional 5,945 shares in the last quarter. Institutional investors and hedge funds own 39.90% of the company’s stock.

Quantum-Si Price Performance

Quantum-Si stock opened at $1.37 on Tuesday. The firm has a fifty day moving average price of $0.88 and a two-hundred day moving average price of $1.07. The firm has a market cap of $195.51 million, a price-to-earnings ratio of -2.14 and a beta of 2.89. Quantum-Si incorporated has a fifty-two week low of $0.61 and a fifty-two week high of $2.43.

Wall Street Analysts Forecast Growth

QSI has been the topic of several research analyst reports. HC Wainwright boosted their price target on shares of Quantum-Si from $4.00 to $5.50 and gave the company a “buy” rating in a report on Thursday, November 21st. Canaccord Genuity Group cut their price objective on Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Wednesday, November 13th.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.